Harlan Waksal, Executive Chair at Lyra Therapeutics, Inc. (LYRA), bought 473,932 shares at $4.22 ($2.0M) on 2022-04-12, disclosed to the SEC on 2022-04-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.22 | 236,966 | $1000K | 50.0% |
| 2 | $4.22 | 236,966 | $1000K | 50.0% |
| Total | $4.22 avg | 473,932 | $2.0M | 100% |
| Filing → |
| KDMN | BUY | 2020-03-11 | $50K | — | Filing → |
| KDMN | BUY | 2017-08-10 | $11K | — | Filing → |
| KDMN | BUY | 2017-08-08 | $9K | — | Filing → |